News

A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobin reduced biological age on average by 2.6 years, as measured by ...
The product was codeveloped by GC Biopharma Corp. and Korea Disease Control and Prevention Agency. GC Biopharma Corp. will buy plasma collector Abo Holdings Inc. in a ₩138 billion (US$96.28 million) ...
This system is particularly well-suited for biopharma production and biorepository needs. With flexible options for chamber depth and door dimensions, you can accommodate a wide range of storage ...
The pharmaceutical industry demands precise, reliable quantitation throughout the entire drug development pipeline, from initial compound screening to final quality control (QC). Older analytical ...
Advanced technologies and close collaboration maximize yields, safety, and patient access to life-saving therapies.
which attract B cells and plasma cells and support the formation of ectopic lymphoid structures. 7 Anti-TNF-α agents: TNF inhibitors (e.g., infliximab, adalimumab) transformed RA treatment by ...
Key findings include: FLT3 inhibition correlated with BMF-500 systemic exposures. Bone marrow and plasma concentrations of BMF-500 and its metabolites were comparable, suggesting good compartmental ...